Nemaura Pharma today reported that it had recently successfully passed its 3-yearly re-certificaiton audit under the Medical Devices Regulations to retain its ISO13485 accreditation. Under this accreditation the company holds a quality management system that complies with the requirements of ISO13485:2016 & EN ISO 13485:2016 for the design, manufacture, and distribution of Transdermal Devices and Continuous Glucose Monitoring Systems. The company continues to place quality at the heart of its operations, as it progresses its numerous Pharmaceutical products and Medical devices from the laboratory to commercial launch.
Menu